Astrana Health, Inc. Cash Flow Statement
ASTH / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Astrana Health, Inc. generated $115M in operating cash flow and $104M in free cash flow in FY2025. Free cash flow margin was 3.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $22.5M | $43.1M | $68.9M | $45.2M | $68.9M | $37.9M | $14.1M | $10.8M | $25.8M | $11.5M | -$9.3M | -$1.8M | -$5.0M | -$720.3K | -$156.3K |
| Depreciation & Amortization | $45.7M | $27.9M | $17.5M | $17.5M | $17.5M | $18.4M | $18.3M | $19.3M | $19.1M | $18.1M | $351.4K | $334.4K | $31.4K | $12.6K | $11.2K |
| Operating Cash Flow | $114.6M | $52.2M | $70.3M | $82.1M | $70.3M | $46.2M | $13.7M | $25.5M | $51.8M | $21.9M | -$1.8M | -$271.9K | -$1.5M | -$385.5K | -$245.0K |
| Capital Expenditures | $10.1M | $8.0M | $19.2M | $22.9M | $19.2M | $1.2M | $1.0M | $1.2M | $2.1M | $3.3M | $262.1K | $44.5K | $22.9K | $7.2K | $21.2K |
| Free Cash Flow | $104.5M | $44.2M | $51.1M | $59.2M | $51.1M | $45.0M | $12.6M | $24.3M | $49.7M | $18.6M | -$2.1M | -$316.4K | -$1.5M | -$392.7K | -$266.2K |
| Share Buybacks | $25.6M | $900.0K | $5.7M | $9.3M | $5.7M | $537.0K | $7.6M | $5.0M | $3.2M | $517.5K | - | $500 | $0 | - | - |
| Dividends Paid | $7.9M | $4.0M | $31.1M | $14.0M | $31.1M | $51.3M | $61.7M | $17.8M | $10.4M | $26.7M | - | - | - | - | - |
| FCF Margin | 3.3% | 2.2% | 6.6% | 5.2% | 6.6% | 6.6% | 2.3% | 4.7% | 14.0% | 32.4% | -4.8% | -1.0% | -14.3% | -7.7% | -6.8% |